Blueprint Medicines Corporation
Office phone +1 617-374-****
Get Phone Number
Homepage http://www.blueprintmedicines.com
LinkedIn Profile https://linkedin.com/company/blu***-medic***
HQ Location
United States , Massachusetts, Cambridge38 Sidney Street Suite 200 Cambridge, MA 02139 United States
Blueprint Medicines Corporation, a biopharmaceutical company, develops drugs of small molecule kinase inhibitors that target genomic drivers in various cancers and a rare genetic disease. Its lead drug candidates include avapritinib, which is in Phase I clinical trials that targets KIT Exon 17 mutant proteins and PDGFRa D842V mutations, that are drivers of cancer and proliferative disorders, including gastrointestinal stromal tumors and systemic mastocytosis; and BLU-554, which is in Phase I clinical trials an orally available, potent, and irreversible inhibitor of the kinase FGFR4 that is activated in a defined subset of patients with hepatocellular carcinoma. It is also developing BLU-667, a drug candidate that targets RET, a receptor tyrosine kinase that is abnormally activated by mutations or translocations; and RET resistant mutants that would arise from treatment with first generation therapies. In addition, the company is developing BLU-782, a discovery program targeting the kinase ALK2 for the treatment of fibrodysplasia ossificans progressiva, a rare genetic disease caused by mutations in the ALK2 gene, ACVR1. The company has an agreement with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc. to discover, develop, and commercialize small molecule therapeutics targeting kinases. The company was formerly known as Hoyle Pharmaceuticals, Inc. and changed its name to Blueprint Medicines Corporation in June 2011. Blueprint Medicines Corporation was founded in 2008 and is headquartered in Cambridge, Massachusetts.
Biotechnology and Molecular Biology Research
Companies in the biotechnology and molecular biology industry use advanced technologies to research and develop products that are used to diagnose or treat diseases. This also involves gene manipulation which can be used to create new medicines or vaccines.
Career Opportunities at Blueprint Medicines Corporation
Stay updated on the latest job openings by checking back regularly or by visiting the company's official career page.
No job listings currently found.
Employees of 'Blueprint Medicines Corporation'
Decision makers at Blueprint Medicines
240 Decision Makers at Blueprint Medicines
Sales at Blueprint Medicines
60 Sales at Blueprint Medicines
Business development at Blueprint Medicines
54 Business Development at Blueprint Medicines
Purchasing & operations at Blueprint Medicines
438 Purchasing & Operations at Blueprint Medicines
Marketing & media at Blueprint Medicines
25 Marketing & Media at Blueprint Medicines
Legal at Blueprint Medicines
16 Legal at Blueprint Medicines
Details of Blueprint Medicines
Related Companies and Competitors
Access All Contact Details
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive to ensure that the information is accurate and up-to-date, we cannot guarantee its completeness or accuracy. We do not endorse or guarantee the products or services of any company or individual listed.
